Metraipolis › archive › dc_bd81680e39ec

Bispecific Antibodies: Strategies Available to Optimize Their Safe Delivery in Patients with Multiple Myeloma — Europe PMC PMID:41562778

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41562778
DOI
10.3390/antib15010005
License (as archived)
solo-consultazione
Archived
2026-11-07T01:30:55.301Z
SHA-256 of the archived text
477f30f0792b079cb3d1798e88c93a9a6629fcc875d023e6d9851a991293c808
Stable URL of this page
https://metraipolis.com/documento/dc_bd81680e39ec

How to cite

Bispecific Antibodies: Strategies Available to Optimize Their Safe Delivery in Patients with Multiple Myeloma — Europe PMC PMID:41562778 — Europe PMC (en), https://europepmc.org/article/MED/41562778 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bd81680e39ec (Metraipolis archive dc_bd81680e39ec, sha256 477f30f0792b079cb3d1798e88c93a9a6629fcc875d023e6d9851a991293c808)
BibTeX
@misc{dcbd81680e39ec,
  title = {Bispecific Antibodies: Strategies Available to Optimize Their Safe Delivery in Patients with Multiple Myeloma — Europe PMC PMID:41562778},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41562778},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bd81680e39ec; sha256 477f30f0792b079cb3d1798e88c93a9a6629fcc875d023e6d9851a991293c808},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41562778. Agents can read the archived copy with the MCP tool read_document.